<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01244347</url>
  </required_header>
  <id_info>
    <org_study_id>FARM 6KWTCT</org_study_id>
    <secondary_id>2008-004334-25</secondary_id>
    <nct_id>NCT01244347</nct_id>
  </id_info>
  <brief_title>Folic Acid Dosage and Malformations Reduction</brief_title>
  <official_title>Randomized Clinical Trial to Evaluate the Efficacy of High Dose of Folic Acid to Prevent the Occurrence of Congenital Malformations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Universitaria Integrata Verona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Centre of Birth Defects</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azienda Ospedaliera Universitaria Integrata Verona</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In 1991 the Medical Research Council Vitamin Study Group and in 1992 the Hungarian randomised
      clinical trial have shown conclusively that the risk of neural tube defects can be reduced
      substantially by taking folic acid during the peri-conceptional period. At present there is
      enough evidence to support the hypothesis that folic acid supplementation can reduce the risk
      of all congenital malformations or of a specific and selected group of them, namely: neural
      tube defects, oral clefts, cardiac defects, urinary tract anomalies except hypospadias, limb
      reduction defects, omphalocele, anal atresia and trisomy 21.

      The hypothesis that a higher intake of folic acid is related to an higher risk reduction of
      neural tube defects and of other congenital malformations is the main rationale for the
      present study.

      The present study is a randomized, double-blind, controlled trial evaluating whether
      supplementation with folic acid at high dose (4 mg/day) reduces the overall risk of major
      congenital malformations in the population more than the standard recommended dose (0.4
      mg/day). At the enrolment visit all the eligible women will be interviewed to assess
      sociodemographic, life style and health status. After randomization, women will be
      interviewed every 4 months to evaluate pregnancy status. Women who have a pregnancy diagnosis
      during the study period will be interviewed by telephone at the expected 16, 24 and 40 weeks
      of gestation to evaluate the pregnancy outcome. The health status of live births will be
      evaluated at the child's age of 1 month, 3 months and 1 year.

      The primary aim of this project is conducting a study to assess the effect of folic acid
      periconceptional supplementation of 4 mg/day compared to the 0.4 mg/day standard dose on
      reducing the occurrence of all congenital malformations. Secondary aims of this study include
      comparing severity of CMs in offspring of trial mothers, rates of &quot;selected congenital
      malformations&quot;, rates of twinning, miscarriages, recurrent abortions, small-for-gestational
      age, preeclampsia and abruptio placentae. The sample size is not easy to be computed because
      lacking robust estimate of the size effect of the treatment. Three hypotheses of a size
      effect of 45%, 26% and 13% were considered. A sample size of outcomes (and women)
      respectively of 2,006 (5,015), 8,510 (21,275) and 30,126 (75,315) is needed. Since the sample
      size needed to evaluate different scenarios is large, the present study is also the pilot
      study to promote an international prospective meta-analysis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of congenital malformations</measure>
    <time_frame>112 weeks</time_frame>
    <description>The time frame was computed as an average of 32 weeks before conception, plus an average of 28 weeks to all possible outcomes, plus 52 weeks of baby observation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of selected congenital malformations</measure>
    <time_frame>112 weeks</time_frame>
    <description>The time frame was computed as an average of 32 weeks before conception, plus an average of 28 weeks to all possible outcomes, plus 52 weeks of baby observation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Miscarriages and recurrent abortions</measure>
    <time_frame>47 weeks</time_frame>
    <description>The time frame was computed as an average of 32 weeks before conception, plus an average of 15 weeks as a mean of time from conception to different clinical conditions related to miscarriage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pre-eclampsia</measure>
    <time_frame>60 weeks</time_frame>
    <description>The time frame was computed as an average of 32 weeks before conception, plus an average of 28 weeks to the occurrence of pre-eclampsia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>abruptio placentae</measure>
    <time_frame>34 weeks</time_frame>
    <description>The time frame was computed as an average of 32 weeks before conception, plus an average of 34 weeks to the occurrence of abruptio placentae.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intrauterine growth restriction</measure>
    <time_frame>31 weeks</time_frame>
    <description>The time frame was computed as an average of 32 weeks before conception, plus an average of 31 weeks to the occurrence of intrauterine growth restriction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pre-term delivery</measure>
    <time_frame>30 weeks</time_frame>
    <description>The time frame was computed as an average of 32 weeks before conception, plus an average of 30 weeks to the occurrence of pre-term delivery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>multiple births</measure>
    <time_frame>24 weeks</time_frame>
    <description>The time frame was computed as an average of 32 weeks before conception, plus an average of 24 weeks to the possible diagnosis of twinnings or delivery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Congenital Malformations</condition>
  <arm_group>
    <arm_group_label>folic acid 4 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>folic acid 0.4 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>folic acid</intervention_name>
    <arm_group_label>folic acid 4 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>folic acid</intervention_name>
    <arm_group_label>folic acid 0.4 mg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 18 and 44 years

          -  women who intend to become pregnant (not excluded women

        Exclusion Criteria:

          -  pregnant women

          -  women planning to move to an area where the study is not ongoing

          -  women who do not understand and speak Italian

          -  women who do not have a phone

          -  women affected by epilepsy, even not assuming anticonvulsivant drugs

          -  women affected by diabetes

          -  women who previously had a tumour or a disease relevant for the study (Crohn disease,
             rheumatoid arthritis, ulcerative colitis)

          -  women who recently assumed antifolates, like methotrexate

          -  women who currently abuse or previously abused alcohol

          -  obese women

          -  vegetarian women

          -  women who had a previous pregnancy with neural tube defect (NTD) or any other
             congenital structural defect

          -  women or partners with NTD, or one of their relatives with an NTD

          -  women with positive family history for breast or colorectal cancer

          -  women with positive family or personal history of hereditary syndrome like adenomatous
             polyposis, or hereditary nonpolyposis colorectal cancer

          -  women allergic to folic acid

          -  women presenting contraindications to folic acid

          -  women affected by megaloblastic anaemia

          -  assuming folic acid at defined doses for conditions other than those already mentioned
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Renata Bortolus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Universitaria Integrata Verona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale di Adria</name>
      <address>
        <city>Adria</city>
        <state>Rovigo</state>
        <zip>45011</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Luca</name>
      <address>
        <city>Trecenta</city>
        <state>Rovigo</state>
        <zip>45027</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Conegliano</name>
      <address>
        <city>Conegliano</city>
        <state>Treviso</state>
        <zip>31015</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Centre</name>
      <address>
        <city>Montebelluna</city>
        <state>Treviso</state>
        <zip>31044</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Practice</name>
      <address>
        <city>Oderzo</city>
        <state>Treviso</state>
        <zip>31046</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Practice</name>
      <address>
        <city>Villorba</city>
        <state>Treviso</state>
        <zip>31020</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Sant'Antonio Abate</name>
      <address>
        <city>Gallarate</city>
        <state>Varese</state>
        <zip>21013</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Practice</name>
      <address>
        <city>Camponogara</city>
        <state>Venezia</state>
        <zip>30010</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Centre</name>
      <address>
        <city>Martellago</city>
        <state>Venezia</state>
        <zip>30030</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Practice</name>
      <address>
        <city>Mira</city>
        <state>Venezia</state>
        <zip>30034</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Centre</name>
      <address>
        <city>Noale</city>
        <state>Venezia</state>
        <zip>30033</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Centre</name>
      <address>
        <city>San Pietro di Stra</city>
        <state>Venezia</state>
        <zip>30031</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Centre</name>
      <address>
        <city>Vogonovo</city>
        <state>Venezia</state>
        <zip>30030</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Bussolengo</name>
      <address>
        <city>Bussolengo</city>
        <state>Verona</state>
        <zip>37012</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Legnago</name>
      <address>
        <city>Legnago</city>
        <state>Verona</state>
        <zip>37045</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di San Bonifacio</name>
      <address>
        <city>San Bonifacio</city>
        <state>Verona</state>
        <zip>37047</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Centre</name>
      <address>
        <city>Bassano</city>
        <state>Vicenza</state>
        <zip>36061</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Bassiano</name>
      <address>
        <city>Bassano</city>
        <state>Vicenza</state>
        <zip>36061</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Practice</name>
      <address>
        <city>Dueville</city>
        <state>Vicenza</state>
        <zip>36031</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Practice</name>
      <address>
        <city>Malo</city>
        <state>Vicenza</state>
        <zip>36034</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Practice</name>
      <address>
        <city>Schio</city>
        <state>Vicenza</state>
        <zip>36014</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Practice</name>
      <address>
        <city>Sovizzo</city>
        <state>Vicenza</state>
        <zip>36050</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Boldrini</name>
      <address>
        <city>Thiene</city>
        <state>Vicenza</state>
        <zip>36016</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Valdagno</name>
      <address>
        <city>Valdagno</city>
        <state>Vicenza</state>
        <zip>36078</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Vicenza</name>
      <address>
        <city>Vicenza</city>
        <state>VI</state>
        <zip>36100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Padova</name>
      <address>
        <city>Padova</city>
        <zip>35100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Centre</name>
      <address>
        <city>Padova</city>
        <zip>35132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Centre</name>
      <address>
        <city>Verona</city>
        <zip>37122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Practice</name>
      <address>
        <city>Verona</city>
        <zip>37126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile Maggiore</name>
      <address>
        <city>Verona</city>
        <zip>37126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Practice</name>
      <address>
        <city>Verona</city>
        <zip>37129</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Health Centre</name>
      <address>
        <city>Verona</city>
        <zip>37131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico G.B. Rossi</name>
      <address>
        <city>Verona</city>
        <zip>37134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.folictrial.org</url>
  </link>
  <reference>
    <citation>Badovinac RL, Werler MM, Williams PL, Kelsey KT, Hayes C. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol. 2007 Jan;79(1):8-15.</citation>
    <PMID>17133404</PMID>
  </reference>
  <reference>
    <citation>Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, Gindler J, Hong SX, Correa A. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999 Nov 11;341(20):1485-90. Erratum in: N Engl J Med. 1999 Dec 9;341(24):1864.</citation>
    <PMID>10559448</PMID>
  </reference>
  <reference>
    <citation>Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet. 2004 Feb 15;125C(1):12-21. Review.</citation>
    <PMID>14755429</PMID>
  </reference>
  <reference>
    <citation>Catov JM, Bodnar LM, Ness RB, Markovic N, Roberts JM. Association of periconceptional multivitamin use and risk of preterm or small-for-gestational-age births. Am J Epidemiol. 2007 Aug 1;166(3):296-303. Epub 2007 May 11.</citation>
    <PMID>17496313</PMID>
  </reference>
  <reference>
    <citation>Czeizel AE, Dud√°s I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992 Dec 24;327(26):1832-5.</citation>
    <PMID>1307234</PMID>
  </reference>
  <reference>
    <citation>Ingrid Goh Y, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can. 2006 Aug;28(8):680-689. doi: 10.1016/S1701-2163(16)32227-7. Review.</citation>
    <PMID>17022907</PMID>
  </reference>
  <reference>
    <citation>Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet. 1991 Jul 20;338(8760):131-7.</citation>
    <PMID>1677062</PMID>
  </reference>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2010</study_first_submitted>
  <study_first_submitted_qc>November 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2010</study_first_posted>
  <last_update_submitted>January 13, 2015</last_update_submitted>
  <last_update_submitted_qc>January 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2015</last_update_posted>
  <keyword>folic acid</keyword>
  <keyword>malformations</keyword>
  <keyword>prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

